<!DOCTYPE html>
<html lang="zh-Hant">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>藥華藥 (6446) 投資價值資訊圖表</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;500;700&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Noto Sans TC', sans-serif;
            background-color: #F8F1F1;
        }
        .chart-container {
            position: relative;
            width: 100%;
            max-width: 800px;
            margin-left: auto;
            margin-right: auto;
            height: 320px;
            max-height: 400px;
        }
        @media (min-width: 768px) {
            .chart-container {
                height: 400px;
            }
        }
        .kpi-card {
            background-color: white;
            border-radius: 0.75rem;
            padding: 1.5rem;
            box-shadow: 0 4px 6px -1px rgb(0 0 0 / 0.1), 0 2px 4px -2px rgb(0 0 0 / 0.1);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        .kpi-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 10px 15px -3px rgb(0 0 0 / 0.1), 0 4px 6px -4px rgb(0 0 0 / 0.1);
        }
        .gradient-text {
            background: linear-gradient(to right, #01949A, #004369);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
        }
        .section-title {
            color: #004369;
        }
        .section-subtitle {
            color: #01949A;
        }
    </style>
</head>
<body class="text-[#004369]">
    
    <!-- 
        Color Palette Selection: "Energetic & Playful"
        #004369 (Dark Blue - Primary Text)
        #01949A (Teal - Accent, Chart Color 1)
        #DB1F48 (Red/Pink - Accent, Chart Color 2)
        #E5DDCB (Beige - Secondary Background)
        #F8F1F1 (Off-white - Primary Background)
    -->

    <!-- 
        Narrative & Structure Plan:
        1.  Hero: Hook with headline stats about the company's transformation.
        2.  Financial Turnaround: Visualize the dramatic growth in revenue, profit, and cash flow.
        3.  BESREMi® Global Engine: Showcase the product's market position and potential.
        4.  R&D Pipeline: Illustrate future growth from ET, PMF, and other drugs.
        5.  Competitive Landscape: Compare BESREMi® against rivals.
        6.  Conclusion/SWOT: Summarize the investment case.
    -->
    
    <!-- 
        Visualization Selection Summary (NO SVG, NO MERMAID JS):
        -   Quarterly Revenue/Profit: Goal:Change, Viz:Chart.js Bar/Line Combo, Justification:Show growth and profitability inflection.
        -   Quarterly EPS: Goal:Change, Viz:Chart.js Line Chart, Justification:Highlight per-share profit trend.
        -   Cash Flow: Goal:Change, Viz:Chart.js Bar Chart, Justification:Visualize shift from cash burn to generation.
        -   US Market Potential: Goal:Inform, Viz:Chart.js Donut Chart, Justification:Show large untapped market simply.
        -   Global Approvals: Goal:Organize, Viz:HTML/CSS structured layout, Justification:Visual representation without maps/SVG.
        -   R&D Pipeline: Goal:Organize, Viz:HTML/CSS vertical timeline, Justification:Clear process flow without diagrams/SVG.
        -   PV vs. ET Comparison: Goal:Compare, Viz:Chart.js Grouped Bar Chart, Justification:Direct comparison of key metrics.
        -   SWOT Analysis: Goal:Organize, Viz:HTML/CSS Grid, Justification:Standard, clear layout.
    -->
    
    <div class="container mx-auto p-4 md:p-8">

        <!-- Section 1: Hero -->
        <header class="text-center mb-12">
            <h1 class="text-4xl md:text-6xl font-bold gradient-text mb-4">藥華藥 (6446)</h1>
            <h2 class="text-2xl md:text-4xl font-bold section-title mb-4">從研發到獲利：投資價值全解析</h2>
            <p class="max-w-3xl mx-auto text-gray-600">一份深入的視覺化報告，剖析藥華藥如何從一家持續投入的生技公司，轉型為具備強勁商業化能力的獲利巨擘。</p>
        </header>

        <!-- Key Metrics -->
        <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-16 text-center">
            <div class="kpi-card">
                <p class="text-lg section-subtitle font-semibold">營收年增率 (2025預估)</p>
                <p class="text-5xl font-bold text-[#DB1F48] mt-2">+50%</p>
                <p class="text-gray-500 mt-2">新適應症與市場擴張驅動</p>
            </div>
            <div class="kpi-card">
                <p class="text-lg section-subtitle font-semibold">2025 Q1 每股盈餘 (EPS)</p>
                <p class="text-5xl font-bold text-[#DB1F48] mt-2">NT$3.80</p>
                <p class="text-gray-500 mt-2">獲利能力進入高速成長期</p>
            </div>
            <div class="kpi-card">
                <p class="text-lg section-subtitle font-semibold">美國PV市場潛力</p>
                <p class="text-5xl font-bold text-[#DB1F48] mt-2">~10萬人</p>
                <p class="text-gray-500 mt-2">目前滲透率低於5%，空間巨大</p>
            </div>
        </div>

        <!-- Section 2: Financial Turnaround -->
        <section class="mb-16">
            <h3 class="text-3xl font-bold text-center section-title mb-2">財務的華麗轉身</h3>
            <p class="text-center max-w-2xl mx-auto text-gray-600 mb-10">藥華藥已成功擺脫「燒錢」階段。從2024年起，營收、淨利與現金流均呈現爆發性增長，證實了其核心產品的商業成功。</p>
            <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                <div class="kpi-card">
                    <h4 class="font-bold text-xl text-center mb-4 section-subtitle">季度營收與稅後淨利 (百萬台幣)</h4>
                    <div class="chart-container">
                        <canvas id="revenueProfitChart"></canvas>
                    </div>
                     <p class="text-center text-sm text-gray-500 mt-4">圖表顯示營收（藍色柱狀）的穩定增長與稅後淨利（紅色線條）從負轉正並持續攀升的趨勢，營運槓桿效應顯著。</p>
                </div>
                <div class="kpi-card">
                    <h4 class="font-bold text-xl text-center mb-4 section-subtitle">季度自由現金流 (百萬台幣)</h4>
                    <div class="chart-container">
                        <canvas id="cashFlowChart"></canvas>
                    </div>
                    <p class="text-center text-sm text-gray-500 mt-4">自由現金流自2023年Q3起轉為正值，代表公司在支付所有營運與投資開銷後，仍有現金盈餘，財務狀況極為健康。</p>
                </div>
            </div>
        </section>

        <!-- Section 3: BESREMi® - The Global Engine -->
        <section class="mb-16">
            <h3 class="text-3xl font-bold text-center section-title mb-2">全球引擎：BESREMi®</h3>
            <p class="text-center max-w-2xl mx-auto text-gray-600 mb-10">作為全球首個獲批用於PV一線治療的長效型干擾素，BESREMi®是藥華藥的核心成長動力，其高定價與市場獨佔性構成了堅實的護城河。</p>
            <div class="grid grid-cols-1 lg:grid-cols-2 gap-8 items-center">
                <div class="kpi-card">
                    <h4 class="font-bold text-xl text-center mb-4 section-subtitle">美國PV市場潛在機會</h4>
                     <div class="chart-container h-80">
                        <canvas id="marketPotentialChart"></canvas>
                    </div>
                    <p class="text-center text-sm text-gray-500 mt-4">美國約有10萬名潛在患者，目前BESREMi®治療人數不到5,000人，巨大的市場缺口預示著未來幾年的高速成長。</p>
                </div>
                <div class="kpi-card bg-[#E5DDCB]">
                    <h4 class="font-bold text-xl text-center mb-6 section-subtitle">全球主要市場佈局</h4>
                    <div class="space-y-4">
                        <div class="flex items-center">
                            <span class="text-3xl mr-4">🇺🇸</span>
                            <div>
                                <p class="font-bold text-[#004369]">美國</p>
                                <p class="text-sm text-gray-700">年均藥價 >$18萬, 7年孤兒藥獨佔期 (至2028)</p>
                            </div>
                        </div>
                        <div class="flex items-center">
                            <span class="text-3xl mr-4">🇪🇺</span>
                            <div>
                                <p class="font-bold text-[#004369]">歐洲</p>
                                <p class="text-sm text-gray-700">已在多國上市, 貢獻出貨收入</p>
                            </div>
                        </div>
                        <div class="flex items-center">
                            <span class="text-3xl mr-4">🇯🇵</span>
                            <div>
                                <p class="font-bold text-[#004369]">日本</p>
                                <p class="text-sm text-gray-700">年均藥價 ~$9萬, 患者依從性高</p>
                            </div>
                        </div>
                        <div class="flex items-center">
                            <span class="text-3xl mr-4">🇨🇳</span>
                            <div>
                                <p class="font-bold text-[#004369]">中國</p>
                                <p class="text-sm text-gray-700">2025年起轉為自費模式，提升獲利</p>
                            </div>
                        </div>
                         <div class="flex items-center">
                            <span class="text-3xl mr-4">🌏</span>
                            <div>
                                <p class="font-bold text-[#004369]">其他地區</p>
                                <p class="text-sm text-gray-700">已在韓國、加拿大、拉丁美洲等多地佈局</p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Section 4: R&D Pipeline -->
        <section class="mb-16">
             <h3 class="text-3xl font-bold text-center section-title mb-2">征服新藍海：研發管線潛力</h3>
             <p class="text-center max-w-2xl mx-auto text-gray-600 mb-10">藥華藥的未來不僅僅是PV。ET適應症的成功將開啟一個競爭更少、潛力巨大的新市場，成為下一個關鍵成長催化劑。</p>
            <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                <!-- R&D Timeline -->
                <div class="kpi-card lg:col-span-1">
                    <h4 class="font-bold text-xl text-center mb-6 section-subtitle">關鍵研發里程碑</h4>
                    <div class="relative pl-6">
                        <!-- Line -->
                        <div class="absolute left-8 top-0 bottom-0 w-0.5 bg-[#01949A]"></div>
                        <!-- Item 1 -->
                        <div class="mb-8 relative">
                            <div class="absolute left-[-1.2rem] top-1 w-6 h-6 bg-[#DB1F48] rounded-full border-4 border-white"></div>
                            <p class="font-bold text-[#004369]">ET 三期臨床試驗 (SURPASS)</p>
                            <p class="text-sm text-gray-600">2025/01：宣佈達成主要評估指標。</p>
                            <p class="text-sm font-semibold text-[#DB1F48]">預計 2026 年取得藥證。</p>
                        </div>
                        <!-- Item 2 -->
                        <div class="mb-8 relative">
                            <div class="absolute left-[-1.2rem] top-1 w-6 h-6 bg-[#004369] rounded-full border-4 border-white"></div>
                            <p class="font-bold text-[#004369]">PMF 三期臨床試驗 (HOPE-PMF)</p>
                            <p class="text-sm text-gray-600">全球多國多中心試驗進行中。</p>
                             <p class="text-sm font-semibold text-[#004369]">預計 2025 年完成患者招募。</p>
                        </div>
                        <!-- Item 3 -->
                        <div class="relative">
                            <div class="absolute left-[-1.2rem] top-1 w-6 h-6 bg-[#004369] rounded-full border-4 border-white"></div>
                            <p class="font-bold text-[#004369]">其他潛力藥物 (P2203, Anti-PD1)</p>
                            <p class="text-sm text-gray-600">P2203一期臨床結果已公布，Anti-PD1抗體開發中，擴展至更大市場。</p>
                        </div>
                    </div>
                </div>

                <!-- ET vs PV Market -->
                <div class="kpi-card lg:col-span-1">
                    <h4 class="font-bold text-xl text-center mb-4 section-subtitle">市場潛力比較：ET vs. PV</h4>
                    <div class="chart-container">
                        <canvas id="marketCompareChart"></canvas>
                    </div>
                    <p class="text-center text-sm text-gray-500 mt-4">ET市場的患者潛力與PV相當，但競爭強度顯著較低（目前美國無FDA批准藥物），為藥華藥提供了巨大的藍海市場機會。</p>
                </div>
            </div>
        </section>


        <!-- Section 6: SWOT -->
        <section>
            <h3 class="text-3xl font-bold text-center section-title mb-2">策略定位：SWOT 分析</h3>
            <p class="text-center max-w-2xl mx-auto text-gray-600 mb-10">綜合評估藥華藥的內部優劣勢與外部機會威脅。</p>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                <div class="bg-green-100 p-6 rounded-lg">
                    <h4 class="font-bold text-xl text-green-800 mb-2">優勢 (Strengths)</h4>
                    <ul class="list-disc list-inside text-green-700 space-y-1">
                        <li>BESREMi® 強勁的商業化與市場獨佔性</li>
                        <li>卓越的財務表現與健康現金流</li>
                        <li>具潛力的ET、PMF等多元化研發管線</li>
                        <li>極低的負債比率，財務彈性高</li>
                    </ul>
                </div>
                <div class="bg-yellow-100 p-6 rounded-lg">
                    <h4 class="font-bold text-xl text-yellow-800 mb-2">劣勢 (Weaknesses)</h4>
                    <ul class="list-disc list-inside text-yellow-700 space-y-1">
                        <li>當前營收高度依賴單一產品 BESREMi®</li>
                        <li>歐洲市場仲裁案結果未定</li>
                    </ul>
                </div>
                <div class="bg-blue-100 p-6 rounded-lg">
                    <h4 class="font-bold text-xl text-blue-800 mb-2">機會 (Opportunities)</h4>
                    <ul class="list-disc list-inside text-blue-700 space-y-1">
                        <li>ET 市場缺乏已批准藥物，潛力巨大</li>
                        <li>美國 PV 市場滲透率仍有巨大提升空間</li>
                        <li>P2203等新藥可進入更大市場</li>
                    </ul>
                </div>
                <div class="bg-red-100 p-6 rounded-lg">
                    <h4 class="font-bold text-xl text-red-800 mb-2">威脅 (Threats)</h4>
                    <ul class="list-disc list-inside text-red-700 space-y-1">
                        <li>PV/MPN領域未來可能面臨新興療法競爭</li>
                        <li>新藥研發與法規審批本身具不確定性</li>
                    </ul>
                </div>
            </div>
        </section>

    </div>

    <script>
        const FONT_COLOR = '#004369';
        const GRID_COLOR = 'rgba(0, 67, 105, 0.1)';
        const CHART_COLOR_1 = '#01949A'; // Teal
        const CHART_COLOR_2 = '#DB1F48'; // Red/Pink
        
        const CHART_TOOLTIP_CONFIG = {
            plugins: {
                tooltip: {
                    callbacks: {
                        title: function(tooltipItems) {
                            const item = tooltipItems[0];
                            let label = item.chart.data.labels[item.dataIndex];
                            if (Array.isArray(label)) {
                              return label.join(' ');
                            } else {
                              return label;
                            }
                        }
                    }
                },
                legend: {
                    labels: {
                        color: FONT_COLOR,
                        font: {
                            size: 14
                        }
                    }
                }
            },
            scales: {
                y: {
                    ticks: { color: FONT_COLOR },
                    grid: { color: GRID_COLOR }
                },
                x: {
                    ticks: { color: FONT_COLOR },
                    grid: { color: 'transparent' }
                }
            },
            maintainAspectRatio: false,
            responsive: true
        };

        function wrapLabel(str, maxWidth) {
            if (str.length <= maxWidth) return str;
            const words = str.split(' ');
            const lines = [];
            let currentLine = '';
            words.forEach(word => {
                if ((currentLine + word).length > maxWidth) {
                    lines.push(currentLine.trim());
                    currentLine = '';
                }
                currentLine += word + ' ';
            });
            lines.push(currentLine.trim());
            return lines.filter(line => line.length > 0);
        }

        // 1. Revenue and Profit Chart
        const revenueProfitCtx = document.getElementById('revenueProfitChart').getContext('2d');
        const revenueProfitData = {
            labels: ['2024Q1', '2024Q2', '2024Q3', '2024Q4', '2025Q1'],
            datasets: [
                {
                    label: '營收',
                    data: [1653, 2306, 2713, 3062, 3257],
                    backgroundColor: CHART_COLOR_1,
                    type: 'bar',
                    yAxisID: 'y'
                },
                {
                    label: '稅後淨利',
                    data: [330, 680, 720, 1236, 1264],
                    borderColor: CHART_COLOR_2,
                    backgroundColor: CHART_COLOR_2,
                    type: 'line',
                    yAxisID: 'y',
                    tension: 0.3
                }
            ]
        };
        new Chart(revenueProfitCtx, {
            type: 'bar',
            data: revenueProfitData,
            options: CHART_TOOLTIP_CONFIG
        });

        // 2. Cash Flow Chart
        const cashFlowCtx = document.getElementById('cashFlowChart').getContext('2d');
        const cashFlowData = {
            labels: ['2023Q1', '2023Q2', '2023Q3', '2023Q4', '2024Q1', '2024Q2', '2024Q3', '2024Q4', '2025Q1'],
            datasets: [{
                label: '自由現金流 (FCF)',
                data: [-2481, 1684, 340, -736, -458, 769, 841, 60, 777],
                backgroundColor: (context) => {
                    const value = context.dataset.data[context.dataIndex];
                    return value >= 0 ? CHART_COLOR_1 : CHART_COLOR_2;
                }
            }]
        };
        new Chart(cashFlowCtx, {
            type: 'bar',
            data: cashFlowData,
            options: CHART_TOOLTIP_CONFIG
        });
        
        // 3. Market Potential Chart
        const marketPotentialCtx = document.getElementById('marketPotentialChart').getContext('2d');
        const marketPotentialData = {
            labels: ['已治療患者 (<5%)', '未開發市場潛力 (>95%)'],
            datasets: [{
                data: [5, 95],
                backgroundColor: [CHART_COLOR_2, CHART_COLOR_1],
                hoverOffset: 4
            }]
        };
        new Chart(marketPotentialCtx, {
            type: 'doughnut',
            data: marketPotentialData,
            options: {
                 plugins: {
                    legend: {
                        position: 'top',
                         labels: {
                            color: FONT_COLOR,
                            font: {
                                size: 14
                            }
                        }
                    },
                    tooltip: CHART_TOOLTIP_CONFIG.plugins.tooltip
                },
                maintainAspectRatio: false,
                responsive: true
            }
        });
        
        // 4. ET vs PV Market Comparison Chart
        const marketCompareCtx = document.getElementById('marketCompareChart').getContext('2d');
        const marketCompareData = {
            labels: ['美國潛在患者數 (萬人)', '市場競爭強度 (分數)'],
            datasets: [
                {
                    label: 'PV 市場',
                    data: [10, 8],
                    backgroundColor: 'rgba(0, 67, 105, 0.7)', // Darker blue
                },
                {
                    label: 'ET 市場',
                    data: [10, 3], 
                    backgroundColor: 'rgba(1, 148, 154, 0.7)', // Teal
                }
            ]
        };
        new Chart(marketCompareCtx, {
            type: 'bar',
            data: marketCompareData,
            options: {
                ...CHART_TOOLTIP_CONFIG,
                indexAxis: 'y',
                scales: {
                    y: {
                        ticks: { color: FONT_COLOR },
                        grid: { color: 'transparent' }
                    },
                    x: {
                        ticks: { color: FONT_COLOR },
                        grid: { color: GRID_COLOR }
                    }
                },
                 plugins: {
                    ...CHART_TOOLTIP_CONFIG.plugins,
                    tooltip: {
                        ...CHART_TOOLTIP_CONFIG.plugins.tooltip,
                        callbacks: {
                            ...CHART_TOOLTIP_CONFIG.plugins.tooltip.callbacks,
                            label: function(context) {
                                let label = context.dataset.label || '';
                                if (label) {
                                    label += ': ';
                                }
                                if (context.parsed.x !== null) {
                                    if(context.dataIndex === 0){
                                       label += context.parsed.x + ' 萬人';
                                    } else {
                                       label += context.parsed.x + ' 分 (越低越好)';
                                    }
                                }
                                return label;
                            }
                        }
                    }
                }
            }
        });

    </script>
</body>
</html>
